Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 EUR | +2.61% | -1.79% | -24.86% |
Sales 2024 * | 64.79M 69.87M | Sales 2025 * | 75.94M 81.91M | Capitalization | 60.08M 64.8M |
---|---|---|---|---|---|
Net income 2024 * | -5M -5.39M | Net income 2025 * | -2M -2.16M | EV / Sales 2024 * | 1.3 x |
Net Debt 2024 * | 24.4M 26.31M | Net Debt 2025 * | 22.75M 24.54M | EV / Sales 2025 * | 1.09 x |
P/E ratio 2024 * |
-16.5
x | P/E ratio 2025 * |
-20.2
x | Employees | 311 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.38% |
Latest transcript on BRAIN Biotech AG
1 day | +2.61% | ||
1 week | -1.79% | ||
Current month | -1.79% | ||
1 month | -12.42% | ||
3 months | -15.38% | ||
6 months | -29.31% | ||
Current year | -24.86% |
Managers | Title | Age | Since |
---|---|---|---|
Adriaan Moelker
CEO | Chief Executive Officer | 60 | 20-01-31 |
Director of Finance/CFO | 54 | 20-04-30 | |
Alexander Pelzer
CTO | Chief Tech/Sci/R&D Officer | 38 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Majerus
CHM | Chairman | 63 | 19-03-06 |
Stephen Catling
BRD | Director/Board Member | 59 | 20-10-13 |
Director/Board Member | 70 | 20-10-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 2.75 | +2.61% | 435 |
24-05-08 | 2.68 | -2.55% | 14,803 |
24-05-07 | 2.75 | +1.10% | 5,285 |
24-05-06 | 2.72 | -2.16% | 14,178 |
24-05-03 | 2.78 | -1.42% | 9,116 |
Delayed Quote Xetra, May 09, 2024 at 11:36 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.86% | 62.92M | |
-23.69% | 227M | |
+35.52% | 75.51M |
- Stock Market
- Equities
- BNN Stock